Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Cairns

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Neural Plasticity|February 17, 2016
The Endocannabinoid System as a Therapeutic Target in GlaucomaElizabeth A Cairns, William H Baldridge, Melanie E M Kelly
Australian Journal of General Practice|September 30, 2021
Medicinal cannabis in the treatment of chronic painLuke A Henderson, Vicki Kotsirilos, Elizabeth A Cairns, et al.
Journal of Basic and Clinical Physiology and Pharmacology|November 14, 2015
Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular diseaseElizabeth A Cairns, J Thomas Toguri, Richard F Porter, et al.
Frontiers in Pharmacology|May 27, 2022
Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five YearsSara L MacPhail, Miguel A Bedoya-Pérez, Rhys Cohen, et al.
Cannabis and Cannabinoid Research|February 17, 2018
The Cannabinoids Δ<sup>8</sup>THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and InflammationDinesh Thapa, Elizabeth A Cairns, Anna-Maria Szczesniak, et al.
The International Journal on Drug Policy|September 12, 2020
Access to cannabidiol without a prescription: A cross-country comparison and analysisIain S McGregor, Elizabeth A Cairns, Sarah Abelev, et al.
Neuropharmacology|May 7, 2013
The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomyJoanna E Slusar, Elizabeth A Cairns, Anna-Maria Szczesniak, et al.
Frontiers in Psychiatry|January 2, 2023
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11Richard C Kevin, Elizabeth A Cairns, Rochelle Boyd, et al.
Molecules (Basel, Switzerland)|January 24, 2020
Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and InflammationDinesh Thapa, Elizabeth A Cairns, Anna-Maria Szczesniak, et al.
Frontiers in Pharmacology|June 22, 2023
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribingElizabeth A Cairns, Melissa J Benson, Miguel A Bedoya-Pérez, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Neural Plasticity|February 17, 2016
The Endocannabinoid System as a Therapeutic Target in GlaucomaElizabeth A Cairns, William H Baldridge, Melanie E M Kelly
Australian Journal of General Practice|September 30, 2021
Medicinal cannabis in the treatment of chronic painLuke A Henderson, Vicki Kotsirilos, Elizabeth A Cairns, et al.
Journal of Basic and Clinical Physiology and Pharmacology|November 14, 2015
Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular diseaseElizabeth A Cairns, J Thomas Toguri, Richard F Porter, et al.
Frontiers in Pharmacology|May 27, 2022
Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five YearsSara L MacPhail, Miguel A Bedoya-Pérez, Rhys Cohen, et al.
Cannabis and Cannabinoid Research|February 17, 2018
The Cannabinoids Δ<sup>8</sup>THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and InflammationDinesh Thapa, Elizabeth A Cairns, Anna-Maria Szczesniak, et al.
The International Journal on Drug Policy|September 12, 2020
Access to cannabidiol without a prescription: A cross-country comparison and analysisIain S McGregor, Elizabeth A Cairns, Sarah Abelev, et al.
Neuropharmacology|May 7, 2013
The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomyJoanna E Slusar, Elizabeth A Cairns, Anna-Maria Szczesniak, et al.
Frontiers in Psychiatry|January 2, 2023
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11Richard C Kevin, Elizabeth A Cairns, Rochelle Boyd, et al.
Molecules (Basel, Switzerland)|January 24, 2020
Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and InflammationDinesh Thapa, Elizabeth A Cairns, Anna-Maria Szczesniak, et al.
Frontiers in Pharmacology|June 22, 2023
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribingElizabeth A Cairns, Melissa J Benson, Miguel A Bedoya-Pérez, et al.
Pageof 3